In today's culture, a drug that's been to congress in one way shape or form couldn't be easily 'shelved'. They would need to scrub a LOT of pages and servers and come up with an bullet proof explanation that the public can swallow. None that I can logically fathom. I highly do not think shelving would be an option. If one can't beat them, at least profit from them, is my take.
Price? I would imagine it would be a mixture of cash/shares. Don't even have an idea on price but to give an idea.. what's the market share on a SUBQ shot to treat LH for 8 weeks with a disease that will stay like the flu and cross the BBB? If you come up with that answer.. let me know. All I can say is, if/when BP does pull the trigger, I'm sure the SP will reflect that immediately..
The above is MY opinion and my opinion only.
Stay tuned, this ride got started but we're about to hit the turbo button. IMO.
GLTU/A.
News 
Market Data 
Discover 
AI
